COMMUNIQUÉS West-GlobeNewswire

Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer’s Disease in Japan
28/11/2025
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, relentless disease TOKYO and CAMBRIDGE, Mass., Nov [...]
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis
28/11/2025
BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Nyxoah Participera à la Piper Sandler 37th Annual Healthcare Conference
27/11/2025
Nyxoah Participera à la Piper Sandler 37 th Annual Healthcare Conference Mont-Saint-Guibert, Belgique – 27 novembre 2025, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société [...]
Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
27/11/2025
Nyxoah to Participate in the Piper Sandler 37 th Annual Healthcare Conference Mont-Saint-Guibert, Belgium – 27 November, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “ [...]
HealthTab™ to Power NHS Pilot
27/11/2025
Bringing Cholesterol-Lowering Injections to U.K. Community Pharmacies VANCOUVER, British Columbia, Nov. 27, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) is pleased to [...]
GENFIT annonce la nomination d’un nouveau Directeur Médical
27/11/2025
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 27 novembre 2025 – GENFIT (Euronext: GNFT) , société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies [...]
GENFIT Announces Appointment of new Chief Medical Officer
27/11/2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 27, 2025 - GENFIT (Euronext: GNFT) , a biopharmaceutical company dedicated to improving the lives of patients with rare and life- [...]
Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs
27/11/2025
The pioneer method combines the nitrosation assay procedure (NAP) with 15N-enriched nitrosating reagents and 15N NMR spectroscopy for a safer Active Pharmaceutical Ingredients manufacturing process MILAN, Nov. 27, 2025 [...]
Communiqué de presse : Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants
27/11/2025
Sanofi investit 50 millions d’euros au Trait pour accélérer la production de médicaments innovants Paris, France, 27 novembre 2025 – Sanofi inaugure aujourd’hui sur son site industriel du Trait, en Normandie, une [...]
Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade
27/11/2025
Recognizes the company’s continued investment and expansion of cell therapy manufacturing and R&D operations in Ghent, reinforcing Flanders’ position as a global biotech hub SOMERSET, N.J. and GHENT, Belgium, Nov. [...]
Un rapport conclut que l’adoption d’un système de codes à barres par le système canadien de soins de santé permettrait d’économiser des milliards chaque année tout en améliorant la sécurité des patients
27/11/2025
TORONTO, 27 nov. 2025 (GLOBE NEWSWIRE) -- Selon un nouveau rapport de Deloitte Canada demandé par GS1 Canada, l’absence d’adoption de normes internationales au Canada, telles que les codes articles internationaux (« [...]
Report finds adoption of barcoding system in Canadian healthcare can save billions annually while supporting patient safety
27/11/2025
TORONTO, Nov. 27, 2025 (GLOBE NEWSWIRE) -- A new report prepared by Deloitte Canada and commissioned by GS1 Canada finds that the lack of nationwide adoption of global standards via Global Trade Item Numbers (GTINs) and [...]
Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation
27/11/2025
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism underscores commitment to women’s health and lifecycle transitions CDU [...]
Change of management at NTG Nordic Transport Group A/S
27/11/2025
Company announcement no. 11 – 25 27 November 2025 Change of management at NTG Nordic Transport Group A/S Appointment of new Group CFO NTG announces the appointment of Tinneke Torpe as the new Group Chief Financial [...]
Kane Biotech Announces New Private Placement Offering
27/11/2025
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today [...]
Cellectis organise un webinaire dédié aux actionnaires français le jeudi 4 décembre 2025
27/11/2025
PARIS, 27 nov. 2025 (GLOBE NEWSWIRE) -- Cellectis (la « Société ») (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour [...]
71,498 Orion Corporation A shares converted into B shares
27/11/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 NOVEMBER 2025 at 9.00 EET 71,498 Orion Corporation A shares converted into B shares In accordance with [...]
Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management
27/11/2025
SHANGHAI, Nov. 27, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Tencent Healthcare jointly launched a [...]
Zelluna ASA: Disclosure of large shareholding
27/11/2025
Reference is made to the stock exchange announcement made by Zelluna ASA (the "Company") on 3 November 2025 regarding the allocation of 5,500,000 new shares in the Company in a private placement (the "Private Placement [...]

Pages